[Medical, legal and ethical aspects of fertility preservation in cancer survivor].
In recent years the number of the young women in fertile age which are oncologically treated is increasing. For these women chemotherapy and radiotherapy introduces potential risk of reproductive dysfunctions. Present techniques of assisted reproduction are offering possibilities to save reproductive functions even after the oncological treatment. As a perspective outlook seems to be frozen premature oocytes with IVM and fertilisation. With these fertility savings methods are naturally coming up some of the ethical and legal issues.
Gynekologicko-porodnická klinika 3. LF UK a FN KV. jozef.zahumensky@fnkv.cz
J
J
Záhumenský
E
E
Kucera
T
T
Kosová
J
J
Zmrhal
M
M
Stejskal
D
D
Stejskal
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001755:Blastocyst; D015925:Cryopreservation; D005260:Female; D059247:Fertility Preservation / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009865:Oocytes; D010053:Ovary; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced; D017741:Survivors
D000970:Antineoplastic Agents